Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-08 Sale | 2023-11-08 8:32 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 3,103 | $0.33 | $1,024 | 23,484 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:11 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 6,854 | $0.33 | $2,262 | 38,587 (Direct) | View |
| 2023-08-08 Sale | 2023-08-09 8:42 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 3,434 | $9.51 | $32,657 | 20,941 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:32 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 66,730 | $0.1255 | $8,375 | 97,516 (Direct) | View |
| 2022-05-27 Purchase | 2022-05-31 4:15 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 34,246 | $1.46 | $49,999 | 34,246 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-07 Exercise | 2023-11-08 8:32 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 6,500 | $0 | 23,484 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 4:11 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 12,500 | $0 | 38,587 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:54 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 8:42 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 6,500 | $0 | 20,941 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:08 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 130,000 | $0 | 554,246 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:28 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 520,000 | $0 | 520,000 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 4:53 pm | N/A 2032-01-19 | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-01-27 Option Award | 2021-01-29 5:30 pm | N/A 2031-01-27 | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 96,500 | $0 | 96,500 (Direct) | View |
| 2020-01-28 Option Award | 2020-01-30 4:26 pm | N/A 2030-01-27 | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 117,000 | $0 | 117,000 (Direct) | View |